Russia rises among trial sites; Aptuit shakes up management;

> Russia is on the rise among European clinical trial sites. Article

> Telrx has bought up Sentrx Safety Solutions, a provider of pharmacovigilance testing services. Story

> CRO Ergomed has signed on to handle a Phase III study for Aeterna Zentaris, a deal that gives the company a sharge of future drug profits. News

> Cyclica and Dalton have united to identify and develop new drug candidates. More

> Aptuit has appointed a new CFO and vice president for business development. Report